Resistance to PD-1 Inhibition Overcome With a Combination Resistance to PD-1 Inhibition Overcome With a Combination

For metastatic melanoma that acquires resistance to PD-1 inhibition, that resistance may be overcome with a combination of the same PD-1 inhibitor and a toll-like receptor agonist, CMP-001.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news